Labcorp stock heads into the open after holding at USD 323.97
Published on 09/18/2026 at 03:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp stock closed at USD 323.97 on the New York Stock Exchange on September 15, 2026, gaining 2.75% compared with the prior session in USD terms. The shares traded between an intraday low near USD 319 and a high around USD 325, keeping the close within the day range and offering investors a recent benchmark ahead of the open.
September 15, 2026 in numbers
Laboratory Corporation of America Holdings Inc. (ISIN US50540R4092) ended the September 15, 2026 New York session at USD 323.97 after starting from a prior close of about USD 315.31, which translates into a 2.75% daily gain. As Ad-hoc-news reported on September 17, 2026, the move followed investors digesting Q2 2026 figures and raised full-year guidance, which supported sentiment toward the stock. The same overview notes that Labcorp shares traded during the September 15, 2026 session between an intraday low near USD 319 and a high around USD 325, indicating a relatively contained intraday pattern despite broader market volatility.
A separate summary cited by IT-Boltwise on September 17, 2026 highlights that the second quarter of 2026 brought revenues of USD 3.73 billion, which formed part of the backdrop for the mid-September price action. The 2.75% advance on September 15, 2026 left Labcorp stock above its prior close and positioned it against a backdrop of mixed sector moves in United States equities during that week, even as volatility persisted in major indices.
Outlook today
Heading into today, there was no new earnings release or specific corporate event from Labcorp dated September 18, 2026 in the available calendars, so investors approach the open with the Q2 2026 results and raised guidance still serving as the most recent fundamental reference point. Broader market conditions, including recent swings in major United States indices and sector exchange-traded funds described by outlets such as Zacks, may also influence Labcorp stock in the next session as investors weigh rate expectations, growth prospects and healthcare sector dynamics alongside the company specific story.
